Академический Документы
Профессиональный Документы
Культура Документы
depression
incidence
natural history
prevalence
stroke
Methods
First in a lifetime stroke patients were recruited from the South
London Stroke Register (SLSR), a prospective population-based
stroke register covering an inner-city population of 271817.5 Data
from patients, registered in the SLSR between January 1, 1995, and
December 31, 2009, and followed up between April 1, 1995 (first 3
months of follow-up assessments), and August 31, 2010, were used
(patients at registration, N=4022).
Patients were registered during the acute phase of stroke and were
then followed up for 3 months after stroke, 1 year after stroke, and annually thereafter. The World Health Organization definition of stroke
was used.6 Follow-up was by postal questionnaire or interview, depending on the capacity of patient to fill in the questionnaire. Such
capacity was judged by the patient, the next of kin, or the field worker
in a preceding follow-up assessment. Patients unable to complete
the follow-up questionnaire, and those not returning them by post,
were telephoned to arrange face-to-face interviews or have another
follow-up questionnaire posted. Patients who could not be followed
up at one time point remained registered and were contacted again
for the following annual assessment. At follow-up, patients were
Received October 4, 2012; final revision received December 21, 2012; accepted December 28, 2012.
From the Division of Health and Social Care Research, Kings College London, London, United Kingdom (L.A., S.A., S.C., C.D.A.W., A.G.R.);
National Institute for Health Research (NIHR) Biomedical Research Centre, Guys and St Thomas NHS Foundation Trust, London, United Kingdom
(C.D.A.W.); and Stroke Unit, Guys and St. Thomas NHS Foundation Trust, St. Thomas Hospital, London, United Kingdom (A.G.R.).
The online-only Data Supplement is available with this article at http://stroke.ahajournals.org/lookup/suppl/doi:10.1161/STROKEAHA.
111.679340/-/DC1.
Correspondence to Luis Ayerbe, 7th Floor, Capital House, 42 Weston Street, London SE1 3QD, United Kingdom. E-mail luis.ayerbe_garcia-mozon@
kcl.ac.uk
2013 American Heart Association, Inc.
Stroke is available at http://stroke.ahajournals.org
DOI: 10.1161/STROKEAHA.111.679340
1106StrokeApril 2013
assessed for depression using the Hospital Anxiety and Depression
Scale (HADS).7 Scores >7 in the HADS depression subscale were
considered depression. HADS has been validated in stroke patients
showing a good performance both when it is used in a face-to-face
interview and when it is self-administered8 (Cronbachs alpha > 0.80;
optimum performance when HADS subscales scores >7 are used to
identify depression, sensitivity: 73.1, and specificity: 81.6).7 Despite
its good performance, HADS is not a diagnostic scale but a screening
tool that indicates risk of depression. However, the term depression
will be used in this article for succinctness in patients with scores >7.
HADS was routinely collected between 1997 and 2010. Patients registered in 1995 (n=299) and 1996 (n=350) received their first HADS
assessment in 1997. Data on HADS were, therefore, not included
from these patients in the respective estimates for early rates of depression. Because HADS cannot be answered by proxy, all information was collected directly from patients. Although patients with
some degree of cognitive or communication impairment can respond
to HADS, no data could be collected from patients with severe cognitive or communication impairment that the field worker, or the patients next of kin in case of postal questionnaire, judged would give
invalid responses.
Statistical Methods
The poststroke incidence of depression was calculated among patients assessed at each time point who were also assessed and not
depressed in the previous follow-up. Poststroke incidence of depression 3 months after stroke was not calculated because there were no
depression assessments before that point. The cumulative incidence
of depression was calculated among patients assessed for depression
at any time point. The prevalence of depression was calculated among
survivors assessed at each time point. The proportion of patients who
became depressed for the first time at each assessment, between 3
months and 15 years after stroke, was calculated among patients with
complete follow-up until each time point. The proportion of patients
depressed at 3 months who recovered each year was calculated among
patients with complete follow-up until each time point. Finally, to estimate recurrence rate, the proportion of patients not depressed at one
time point, becoming depressed in the following one and having a previous episode of depression reported, was calculated among patients
who had 3 follow-up assessments. Sociodemographic and clinical
characteristics of survivors completing and not completing HADS
were compared using 2 test because these variables were categorical.
As a first step, all estimates were obtained only from patients with
complete data (ie, complete case [CC] analysis). However, estimates
obtained from CC analysis may be biased if the excluded individuals are systematically different from those included. Therefore, in
a second step, estimates were calculated using inverse probability
weighting (IPW).9 Using IPW, cases were weighted by the inverse
of their probability of being a CC. To weight the probability of being
complete, a variable of completeness was created for each estimate.
For example, prevalence of depression at 3 months is 1=observed and
0=missing. A logistic regression model was built to identify predictors of completeness. Variables included in the models were those
considered to be associated with completeness: age, sex, ethnicity,
stroke severity measures (Glasgow Coma Scale, incontinence, and
paresis), and disability at baseline. The inverse of the probability of
being a CC was calculated and applied to individuals with available
data. Finally, estimates were calculated on weighted data. Weighted
and CC estimates are presented. For cases with weight >25, only CC
estimates are presented because IPW can also introduce error when
weights are very large.9 IPW was not used to estimate rate of recurrences because the number of patients available each year was too
low, between 1 and 68, to allow for a stable model of completeness
to be built.10
Some estimates, particularly those obtained with small number of
patients toward the end of the follow-up, had confidence intervals
with values >1 or <0. In these cases, the arcsine correction was used.11
When this correction was used, IPW was not possible; therefore, only
CC estimates were reported.
Ethics
Patients or their relatives gave written informed consent. The study
was approved by the ethics committees of Guys and St Thomas
Hospital NHS Foundation Trust, Kings College Hospital Foundation,
National Hospital for Neurology and Neurosurgery, Queens Square
Hospital, St Georges Hospital, and Chelsea and Westminster
Hospital.
Results
Between 1995 and 2009, the SLSR registered 4022 patients.
When the follow-up period finished in August 2010, the follow-up time for survivors ranged from 3 months to 15 years.
The number of patients registered in each period, assessed
for depression or lost to follow-up, at each time point, is
presented in the online-only Data Supplement I. The maximum number of participants available for analysis was 1233,
1 year after stroke. Few differences were observed between
sociodemographic characteristics of patients who were and
those who were not assessed for depression (online-only Data
Supplement II). Up to 10 years after stroke, those who had had
more severe strokes were less likely to be assessed (onlineonly Data Supplement III).
The poststroke incidence of depression after stroke ranged
between 7% and 21% per year during the 15-year follow-up
(Table 1; online-only Data Supplement III). The proportion
of patients depressed at 3 months, first cases after stroke,
was 33%. The prevalence of depression ranged from 29% to
39% during the follow-up period (Table 2; online-only Data
Supplement IV). Cumulative incidence of depression was
55.4% (53.3%57.5%) on CC analysis and 58.2% (52.9%
60.5%) using IPW. Thirty-three percent of the assessed
patients had their first detected episode of poststroke depression 3 months after the acute event, and this proportion gradually decreased to 4% in year 9. There were no observations of
patients having their first episode of depression from year 10
onward (Table 3). Half of the patients who were depressed at
3 months had recovered from depression at 1 year. The other
half recovered gradually between years 2 and 9. No cases of
depression at 3 months recovering after year 9 were observed
(Table 4). The proportion of recurrent cases rose from 38% in
year 2 to 100% in years 14 and 15 (Table 5).
Weighted and CC estimates of prevalence, poststroke incidence, cumulative incidence, time of onset, and duration were
consistent at all time points.
Discussion
These analyses and estimates show that the natural history of
depression after stroke is dynamic. Depression affects more
than half of all stroke patients at some point, with a stable
prevalence of ~30% up to 15 years after stroke, with most
patients recovering from depression after a few years and having a significant risk of recurrent episodes in the long term.
This study shows a prevalence of depression similar to the
one previously reported in other studies, although the follow-up
is substantially longer.2,3 Poststroke incidence is an estimate
of natural history that has been scarcely investigated.2,12,13
The prevalence and poststroke incidence observed in this
study, which are largely stable throughout the follow-up, are
estimates suggesting a persisting risk of depression among
Patient at Risk
Depression
518
85
16.4 (13.219.6)
17.8 (14.021.6)
488
93
19.1 (15.622.6)
20.5 (16.624.5)
423
69
16.3 (12.819.8)
16.9 (13.020.8)
498
85
17.1 (13.720.4)
17.5 (13.721.2)
356
58
16.3 (12.420.1)
18.5 (13.823.1)
281
42
14.9 (10.719.1)
14.11 (9.518.7)
268
52
19.4 (14.624.2)
22.3 (16.128.6)
205
27
13.2 (8.517.8)
15.2 (9.421.1)
159
27
17.0 (11.122.9)
17.9 (11.024.9)
10
113
22
19.5 (12.026.9)
21.6 (11.931.2)
11
94
15
15.9 (8.423.5)
NR
12
66
12
18.2 (8.627.7)
NR
13
43
20.9 (8.333.6)
NR
14
15
6.7 (0.226.4)*
NR
15
14.3 (0.350.1)*
NR
Because patients who were lost to follow-up for 1 year remained registered and were contacted again the following year, the number of patients at risk may be higher
than the number of patients at risk, minus the number of incident cases, in the previous assessment. CI indicates confidence interval; and NR, not reported.
*Proportions calculated using arcsine correction.
Weights >25 were considered too high.
Estimate not reported as arcsine correction cannot be used, and weighted estimates included CIs with values >1 or <0.
Patients Assessed at
Each Time Point
3m
1101
Patients Depressed
361
32.8 (30.035.6)
33.2 (30.036.4)
1, y
1233
357
28.9 (26.431.5)
30.6 (27.733.5)
2, y
901
266
29.5 (26.532.5)
30.7 (27.434.0)
3, y
1100
340
30.9 (28.233.6)
31.6 (28.734.5)
4, y
890
268
30.1 (27.133.1)
31.0 (27.834.2)
5, y
658
194
29.5 (26.033.0)
30.4 (26.734.1)
6, y
600
179
29.8 (26.233.5)
29.5 (25.633.4)
7, y
475
151
31.8 (27.636.0)
32.1 (27.636.5)
8, y
392
113
28.8 (24.333.3)
29.8 (25.034.6)
9, y
296
106
35.8 (30.341.3)
37.6 (31.743.4)
10, y
234
81
34.6 (28.540.1)
34.4 (28.040.7)
11, y
183
54
29.5 (22.836.2)
30.5 (23.537.6)
12, y
116
37
31.9 (23.340.5)
31.5 (22.640.5)
13, y
72
28
38.9 (27.350.4)
35.9 (24.047.9)
14, y
46
14
30.4 (16.644.2)
34.4 (18.550.3)
15, y
16
31.2 (5.756.8)
32.3 (2.262.4)
1108StrokeApril 2013
Table 3. Proportion of Patients (With Complete Follow-up) With New Cases of Depression Annually
Follow-up
3 mo
1101
361
32.8 (30.035.6)
33.2 (30.036.4)
1, y
750
85
11.3 (9.013.6)
12.0 (9.414.7)
2, y
450
40
8.9 (6.211.5)
9.4 (6.412.3)
3, y
329
17
5.2 (2.87.6)
5.6 (2.88.3)
4, y
249
16
6.4 (3.39.5)
5.2 (2.58.0)
5, y
154
1.9 (0.44.9)*
NR
6, y
87
NR
7, y
44
8.3 (0.216.4)
NR
8, y
36
NR
9, y
27
3.7 (0.0915.4)*
NR
10, y
14
NR
11, y
11
NR
12, y
NR
13, y
No observations
14, y
No observations
15, y
No observations
Recovery Time, y
Patients With
Depression at 3 mo With
Complete Follow-up
Patients With
Depression at 3 mo
Recovered for the First Time
Proportion of Patients
Depressed at 3 mo Recovered
for the First Time (95% CI)
Weighted Proportion of
Patients Depressed at 3 mo
Recovered for the First Time (95% CI)
232
116
50.0 (43.556.5)
50.3 (43.157.6)
139
19
13.7 (7.919.4)
13.9 (7.320.4)
92
7.6 (2.113.1)
8.1 (1.614.7)
74
4.0 (0.910.1)*
NR
41
2.4 (0.0610.3)*
NR
26
3.8 (0.115.9)*
NR
12
NR
NR
14.3 (0.350.1)*
NR
10
NR
11
NR
12
NR||
13
14
15
Follow-up, y
No. of Incident
Cases With 3
Assessments
Proportion of
Recurrent Cases
65
25
38.5 (26.350.6)
57
26
45.6 (32.358.9)
68
29
42.6 (30.654.7)
54
31
57.4 (43.871.0)
40
27
67.5 (52.382.7)
51
31
60.7 (46.974.6)
26
20
76.9 (59.694.3)
27
17
63.0 (43.582.4)
10
22
17
77.3 (58.296.3)
11
15
12
80.0 (55.0100.0)*
12
12
10
83.3 (56.7100.0)*
13
87.5 (54.999.7)*
14
100
15
100
Acknowledgments
We thank all patients and healthcare professionals involved. Particular
thanks to field workers and the team working since 1995 for the South
London Stroke Register and the Stroke Research Team at Kings
College London.
Sources of Funding
The study was funded by Guys and St Thomas Hospital Charity,
The Stroke Association, Department of Health HQIP grant,
UK, National Institute for Health Research Program Grant (RPPG-0407-10184). Charles D.A. Wolfe acknowledges financial support from the Department of Health via the National Institute for
Health Research (NIHR) Biomedical Research Center award to Guys
and St Thomas NHS Foundation Trust in partnership with Kings
College London.
Disclosure
Charles D.A. Wolfe is an NIHR Senior Investigator. This article presents independent research commissioned by the National Institute
for Health Research (NIHR) under its Program Grants for Applied
Research funding scheme (RP-PG-0407-10184). The views expressed in this article are those of the authors and not necessarily
those of the National Health Service, the NIHR, or the Department of
Health. The other authors have no conflicts to report.
References
1. Wolfe CD, Crichton SL, Heuschmann PU, McKevitt CJ, Toschke AM,
Grieve AP, et al. Estimates of outcomes up to ten years after stroke:
analysis from the prospective South London Stroke Register. PLoS Med.
2011;8:e1001033.
2. Ayerbe L, Ayis S, Wolfe C, Rudd A. A systematic review and metaanalysis of depression after stroke, its natural history, predictors, and
outcomes. Br J Psychiatry. 2013;202:1421.
3. Hackett ML, Yapa C, Parag V, Anderson CS. Frequency of depression after stroke: a systematic review of observational studies. Stroke.
2005;36:13301340.
4. Hackett ML, Anderson CS, House A, Xia J. Interventions for treating
depression after stroke. Cochrane Database Syst Rev. 2008:CD003437.
5. Heuschmann PU, Grieve AP, Toschke AM, Rudd AG, Wolfe CD.
Ethnic group disparities in 10-year trends in stroke incidence and vascular risk factors: the South London Stroke Register (SLSR). Stroke.
2008;39:22042210.
1110StrokeApril 2013
6. Hatano S. Experience from a multicentre stroke register: a preliminary
report. Bull World Health Organ. 1976;54:541553.
7. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the
Hospital Anxiety and Depression Scale. An updated literature review. J
Psychosom Res. 2002;52:6977.
8. Aben I, Verhey F, Lousberg R, Lodder J, Honig A. Validity of the beck
depression inventory, hospital anxiety and depression scale, SCL-90, and
Hamilton depression rating scale as screening instruments for depression
in stroke patients. Psychosomatics. 2002;43:386393.
9. Seaman SR, White IR. Review of inverse probability weighting for dealing with missing data. Stat Methods Med Res. 2011.
10. Counsell C, Dennis M. Systematic review of prognostic models in
patients with acute stroke. Cerebrovasc Dis. 2001;12:159170.
11. Gleason J. Improved confidence intervals for binomial proportions. Stata
Tech Bull. 1999:1618.
12. Farner L, Wagle J, Engedal K, Flekky KM, Wyller TB, Fure B. Depressive
symptoms in stroke patients: a 13 month follow-up study of patients
referred to a rehabilitation unit. J Affect Disord. 2010;127:211218.
13. Wade DT, Legh-Smith J, Hewer RA. Depressed mood after stroke. A
community study of its frequency. Br J Psychiatry. 1987;151:200205.
14. Astrm M, Adolfsson R, Asplund K. Major depression in stroke patients.
A 3-year longitudinal study. Stroke. 1993;24:976982.
15. Kase CS, Wolf PA, Kelly-Hayes M, Kannel WB, Beiser A, DAgostino
RB. Intellectual decline after stroke: the Framingham Study. Stroke.
1998;29:805812.
16. House A, Dennis M, Mogridge L, Warlow C, Hawton K, Jones L. Mood
disorders in the year after first stroke. Br J Psychiatry. 1991;158:8392.
SUPPLEMENTAL MATERIAL
Follow up time
Registration period
since stroke
3 months
1995-2009 N=4022
1 year
Dead<1y=1541
1995-2009 N=3957
2 year
Dead<2y=1523
LTF=954
FU=1263
HADS=901
(40.6%)
1995-2008 N=3740
3 year
Dead<3y =1652
LTF=556
FU=1316
HADS=1100 (58.8%)
1995-2007 N=3524
4 year
Dead <4y=1695
LTF=498
FU=1094
HADS=890 (55.9%)
1995-2006 N=3287
5 year
Dead <5y=1728
LTF=517
FU=820
HADS=658 (49.2%)
1995-2005 N=3065
6 year
Dead <6y=1702
LTF=395
FU=710
HADS=600 (54.3%)
1995-2004 N=2807
7 year
Dead <7y=1664
LTF=330
FU=568
HADS=475 (52.9%)
1995-2003 N=2562
8 year
Dead <8y=1563
LTF=251
FU=474
HADS=392 (54.1%)
1995-2002 N=2288
9 year
LTF=211
FU=356
HADS=296 (52.2%)
1995-2001N=2018
10 year
Dead <10y=1297
LTF=167
FU=262
HADS=234 (54.5%)
1995-2000 N=1726
11 year
Dead <11y=1165
LTF=134
FU=203
HADS=183 (54.3%)
1995-1999 N=1502
12 year
Dead <12y=966
LTF=99
FU=128
HADS=116 (51.1%)
1995-1998 N=1193
13 year
Dead <13y=704
LTF=63
FU=96
HADS=72 (45.3%)
1995-1997 N=863
14 year
Dead <14y=451
LTF=40
FU=51
HADS=46 (47.4%)
1995-1996 N=542
15 year
Dead<15y =172
LTF=16
FU=16
HADS=16 (50.0%)
1995-1996 N=204
LTF=558
FU=1858
HADS=1233## (51.0%)
Supplement 1. Number of participants included in the analysis at each follow up time point
N= number of patients registered.
3m
64.3/64.9
46.0/47.4
71.1/70.1
22.7/23.2
1y
61.0/65.3
44.6/46.2
71.1/68.3
22.7/24.8
2y
59.3/59.5
44.9/44.1
66.7/69.3
26.1/24.0
3y
57.4/55.6
42.6/45.2
70.5/62.8
23.4/27.7
4y
54.0/55.4
45.6/40.7
68.6/62.6
24.7/28.2
5y
49.8/55.3
41.6/43.8
68.3/64.5
23.8/27.3
6y
50.7/50.7
43.8/42.4
69.2/61.5
24.2/29.4
7y
49.3/48.2
42.5/40.7
68.9/59.9
25.2/31.7
8y
44.1/47.2
38.8/44.2
64.2/63.8
29.4/28.0
9y
38.8/46.9
41.2/39.8
67.9/60.3
25.6/30.7
10y
37.6/44.4
41.4/41.8
67.9/58.1
24.8/33.5
11y
44.8/35.7
38.8/42.2
69.6/61.4
23.8/30.7
12y
39.7/35.1
36.2/43.2
70.7/56.0
22.4/38.5
13y
33.3/40.2
36.1/44.8
68.1/61.2
27.8/30.6
14y
37.0/39.1
39.1/37.0
66.7/63.0
31.1/30.4
15y
43.7/50
56.2/25.0
66.7/56.2
26.7/37.5
Urine
continence No paresis
Barthel
Index=20
(%)
(%)
(%)
(%)
3m
90.0/84.3
73.3/64.0
26.8/24.9
32.5/29.1
1y
90.7/84.1
75.0/65.2
30.2/22.3
37.8/26.3
2y
89.5/86.8
77.2/68.6
30.7/24.5
41.2/28.7
3y
88.7/86.5
75.3/68.2
28.9/26.0
37.0/32.7
4y
90.6/86.3
76.6/69.1
30.8/25.4
40.6/33.7
5y
89.7/88.4
78.7/71.3
33.1/25.4
41.9/36.9
6y
90.6/85.8
81.8/69.3
32.2/25.7
44.4/34.3
7y
90.2/86.1
80.0/72.6
33.9/25.6
43.1/36.3
8y
90.1/85.7
79.9/72.8
32.9/28.3
42.1/38.0
9y
89.4/87.1
83.0/71.1
33.6/27.6
46.4/32.4
10y
87.9/87.8
80.2/72.2
33.5/27.4
44.3/32.9
11y
88.9/85.2
79.8/67.6
33.7/29.3
41.0/28.2
12y
85.1/86.2
74.3/71.3
27.8/28.2
38.2/29.9
13y
81.7/88.4
70.4/71.8
18.1/25.6
25.7/35.8
14y
87.0/91.3
73.9/78.3
17.4/19.6
31.8/35.6
15y
93.7/93.7
81.2/75.0
18.7/18.7
40.0/56.2
Supplement 3. Comparison of the stroke clinical characteristics of survivors assessed, and not
assessed, with HADS at each time point
p<0.05
p<0.01
Survivors who did not complete the HADS were either lost to follow up or unable
complete the HADS due to cognitive or communication impairment.
60
50
40
30
Post stroke
Incidence (%)
20
10
9
Time (years)
12
15
60
50
40
30
Prevalence %
20
10
6 Time (years)
12
15
The Natural History of Depression up to 15 Years After Stroke: The South London Stroke
Register
Luis Ayerbe, Salma Ayis, Siobhan Crichton, Charles D.A. Wolfe and Anthony G. Rudd
Stroke. 2013;44:1105-1110; originally published online February 12, 2013;
doi: 10.1161/STROKEAHA.111.679340
Stroke is published by the American Heart Association, 7272 Greenville Avenue, Dallas, TX 75231
Copyright 2013 American Heart Association, Inc. All rights reserved.
Print ISSN: 0039-2499. Online ISSN: 1524-4628
The online version of this article, along with updated information and services, is located on the
World Wide Web at:
http://stroke.ahajournals.org/content/44/4/1105
Permissions: Requests for permissions to reproduce figures, tables, or portions of articles originally published
in Stroke can be obtained via RightsLink, a service of the Copyright Clearance Center, not the Editorial Office.
Once the online version of the published article for which permission is being requested is located, click
Request Permissions in the middle column of the Web page under Services. Further information about this
process is available in the Permissions and Rights Question and Answer document.
Reprints: Information about reprints can be found online at:
http://www.lww.com/reprints
Subscriptions: Information about subscribing to Stroke is online at:
http://stroke.ahajournals.org//subscriptions/